These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3517409)

  • 1. [Breakdown of immunological surveillance].
    Hosokawa M
    Nihon Rinsho; 1986 Feb; 44(2):305-10. PubMed ID: 3517409
    [No Abstract]   [Full Text] [Related]  

  • 2. The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.
    Fujiwara H; Hamaoka T; Shearer GM; Yamamoto H; Terry WD
    J Immunol; 1980 Feb; 124(2):863-9. PubMed ID: 6965392
    [No Abstract]   [Full Text] [Related]  

  • 3. On immunosurveillance in human cancer.
    Thomas L
    Yale J Biol Med; 1982; 55(3-4):329-33. PubMed ID: 6758376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological monitoring of renal allograft recipients using monoclonal antibodies to human T lymphocyte subpopulations.
    Ellis TM; Berry CR; Mendez-Picon G; Goldman MH; Lower RR; Lee HM; Mohanakumar T
    Transplantation; 1982 Mar; 33(3):317-9. PubMed ID: 6461117
    [No Abstract]   [Full Text] [Related]  

  • 5. Evasion of host defences by tumours.
    Nelson DS; Nelson M
    Immunol Cell Biol; 1987 Aug; 65 ( Pt 4)():287-304. PubMed ID: 3315983
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of the escape of tumor P1798(SC) from immunologic control in hybrid mice (Balb/c X AKR)F1 (BAF1)].
    Ubeira FM; Seoane R; Puentes E; Faro J; Regueiro BJ
    Rev Esp Oncol; 1982; 29(4):711-6. PubMed ID: 6985427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of covalently bound cord factor analog to increase tumor immunogenicity.
    Eggers AE; Tarmin L; Ginsburg S
    J Biol Response Mod; 1984 Aug; 3(4):413-22. PubMed ID: 6332882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms].
    Rupniewska ZM; Adamczyk MB
    Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960
    [No Abstract]   [Full Text] [Related]  

  • 9. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
    Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
    Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495
    [No Abstract]   [Full Text] [Related]  

  • 10. Promises and limitations of murine models in the development of anticancer T-cell vaccines.
    Lévy F; Colombetti S
    Int Rev Immunol; 2006; 25(5-6):269-95. PubMed ID: 17169777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumour immunology: alternative perspectives.
    Seljelid R
    Scand J Immunol; 1997 Nov; 46(5):437-44. PubMed ID: 9393625
    [No Abstract]   [Full Text] [Related]  

  • 13. Mode of action of immunological adjuvants.
    Allison AC
    J Reticuloendothel Soc; 1979 Dec; 26(Suppl):619-30. PubMed ID: 392086
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunology in tumor therapeutics: an overview.
    Barber HR
    Del Med J; 1980 Apr; 52(4):197-209. PubMed ID: 6153996
    [No Abstract]   [Full Text] [Related]  

  • 15. Principles of tumor immunology.
    Den Otter W
    Postepy Hig Med Dosw; 1988; 42(2):117-24. PubMed ID: 3075997
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
    Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of prostaglandins in immunological reactions].
    Zaorska B
    Pediatr Pol; 1981 Mar; 56(3):335-9. PubMed ID: 7019836
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunosuppression mechanism affecting the development of neoplasms].
    Rupniewska ZM; Kurowska M
    Pol Tyg Lek; 1980 Mar; 35(12):455-7. PubMed ID: 6966796
    [No Abstract]   [Full Text] [Related]  

  • 19. [The cancer-immunity relation].
    Sáiz García F; Rodríqez Valverde V; Agüero Balbín R
    Rev Clin Esp; 1982 Feb; 164(4):219-23. PubMed ID: 7089344
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunology of cancer: basic experiments and clinical progress (author's transl)].
    Pasternak G
    Arch Geschwulstforsch; 1973; 42(4):345-57. PubMed ID: 4138903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.